Back
Allegiant Travel Vs. Akero Therapeutics Industry Stock Comparison
Sell
27
ALGT
Allegiant Travel
Last Price:
$51.03
Seasonality Move:
-1.91%
Buy
64
AKRO
Akero Therapeutics
Last Price:
$55.60
Seasonality Move:
13.24%
Sell
27
Allegiant Travel (ALGT)
is a Sell
Is Allegiant Travel a Buy, Sell or Hold?
-
The current Allegiant Travel [ALGT] share price is $51.05. The Score for ALGT is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
-
ALGT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
64
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $55.62. The Score for AKRO is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
-
AKRO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ALGT Stock Price Chart
What is Allegiant Travel's stock price today?
-
The Allegiant Travel share price today is $51.05Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALGT is experiencing slight selling pressure.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $55.62Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing buying pressure, which is a positive indicator for future bullish movement.
ALGT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.44 | Buy |
Relative Strength Index (14 RSI): | 42.22 | Sell |
Chaikin Money Flow: | -107611 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (53.45 - 57.55) | Sell |
Bollinger Bands (100): | (44.81 - 82.41) | Sell |
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.22 | Buy |
Relative Strength Index (14 RSI): | 69.42 | Buy |
Chaikin Money Flow: | 1967952 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (41.81 - 53.51) | Buy |
Bollinger Bands (100): | (37.5 - 51.86) | Buy |
ALGT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 55.51 | Sell |
20-day SMA: | 55.19 | Sell |
50-day SMA: | 51.14 | Sell |
200-day SMA: | 65.66 | Sell |
8-day EMA: | 54.67 | Sell |
20-day EMA: | 54.75 | Sell |
50-day EMA: | 55.33 | Sell |
200-day EMA: | 63.25 | Sell |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 54.07 | Buy |
20-day SMA: | 49.61 | Buy |
50-day SMA: | 43.75 | Buy |
200-day SMA: | 36.79 | Buy |
8-day EMA: | 53.49 | Buy |
20-day EMA: | 50.33 | Buy |
50-day EMA: | 46.33 | Buy |
200-day EMA: | 38.56 | Buy |
Allegiant Travel Earnings Growth & ALGT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.77 per share, an increase next quarter of $3.01 per share, an increase this year of $0.98 per share, and an increase next year of $3.28 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and a decrease next year of $0.64 per share.
Allegiant Travel Technical Analysis
Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akero Therapeutics Technical Analysis
Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |